LT Topical Cream, Lidocaine/Tetracaine, 23%/7%, 60gm per jar, Multiple Dose Container for Topical...

FDA Recall #D-0436-2022 — Class II — December 6, 2021

Recall #D-0436-2022 Date: December 6, 2021 Classification: Class II Status: Terminated

Product Description

LT Topical Cream, Lidocaine/Tetracaine, 23%/7%, 60gm per jar, Multiple Dose Container for Topical Use, Edge Pharma, LLC, 856 Hercules, VT, Colchester, VT 05446, NDC 05446-1647-01

Reason for Recall

CGMP Deviations

Recalling Firm

Edge Pharma, LLC — Colchester, VT

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

74 jars

Distribution

nationwide

Code Information

08-2021-23@9 02-19-2022, 09-2021-07@13 03-06-2022 & 10-2021-22@5 04-20-2022.

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated